Source: International Congress 2015 – The immunology of allergic airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gulbahor Fazilova (Samarkand, Uzbekistan), Gulbahor Fazilova. Importance of levels production of Il-4 in the pathogenesis and formation of the phenotype of asthma. Eur Respir J 2015; 46: Suppl. 59, 2550

Member's Comments

No comment yet.

Related content which might interest you: TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 Increased serum levels of soluble IL-18 receptor complex in allergic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 The homologous IL-17 cytokines A and F differentially regulate allergic asthma in murine models Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 The role of IL-13, IL-4Rα cytokine gene variants in atopic and non-atopic asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Immunomodulatory role of IL-37 in asthma pathogenesis Source: International Congress 2016 – Immune responses in the lung Year: 2016 shRNA suppresses of IL-13 production in vitro Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Aquaporin-3 potentiates murine asthma through mediating T-cell trafficking and chemokine production Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Impaired synthesis and transport of immunoglobulin A in severe asthma: Role of IL-13 Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Correlation between asthma control and serum levels of IL-33 in atopic asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 IL5 and IL13 modulate trans-compartmental activation and migration of eosinophils Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 TSLP as biomarker in asthma patients Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 ADEPT-derived, U-BIOPRED validated asthma clinical clusters with Th2 and non-Th2 phenotypes Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 The effect of oligomeric proanthocyanidin on airway microenvironment in asthma Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Eosinophilic airway inflammation is associated with increased TLR2 and TLR4 expression in adult asthmatics Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 Imbalance of pro-inflammatory and anti-inflammatory markers on circulating dendritic cells in COPD Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014